Mbtm1.1(EGFP/cre/ERT2)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Mbtm1.1(EGFP/cre/ERT2)Wtsi |
| Name: |
myoglobin; targeted mutation 1.1, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:5633782 |
| Synonyms: |
Mbtm1.1(EGFP/cre/ERT2)Hmgu |
| Gene: |
Mb Location: Chr15:76899687-76934868 bp, - strand Genetic Position: Chr15, 36.36 cM
|
| Alliance: |
Mbtm1.1(EGFP/cre/ERT2)Wtsi page
|
|
| Mutant Cell Line: |
CEPD0005_3_F06 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:204812
|
| Parent Cell Line: |
JM8.N4 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
| Project Collection: |
EUCOMMTOOLS
|
|
| Allele Type: |
|
Targeted (Conditional ready, Inducible, Recombinase, Reporter) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Mbtm1.1(EGFP/cre/ERT2)Wtsi expression driven by
1 gene
Knock-in expression driven by:
| Organism |
Driver Gene |
Note |
| mouse |
Mb (MGI:96922) |
|
|
| |
|
Mutation details: According to the allele molecular image presented by the International Knockout Mouse Consortium, this allele has loxP sites flanking exons 2 through 3, and inserted into the intron between exons 1 and 2 is one FRT site, an engrailed 2 splice acceptor sequence, an EGFP and cre/ERT2 expression cassette, and a single Rox site remaining after a flanked puromycin resistance cassette removal.
(J:155845)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Mb
(mouse)
|
| |
|
|
|
|
| Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
| All: |
2 reference(s) |
|
Analysis Tools
